Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Angel, Astrazeneca, Atai Life Sciences, Azura Ophthalmics, Biontech, Biosyngen, Corvus, Everest Medicines, Legend, Lepu, Maruishi, Merck, Pfizer.